Inhibition of astrocytic glycine transporter-1: friend or foe for ameliorating NMDA receptor hypofunction?

This document is a compilation of scientific articles and studies that explore the role of glycine transporters in schizophrenia and other psychiatric disorders. The articles discuss the mechanisms of glycine release and the potential therapeutic targets for treating schizophrenia. They also examine the effects of glycine augmentation on symptoms and explore the use of glycine transporter inhibitors as potential treatments for cognitive impairment and negative symptoms associated with schizophrenia. [Extracted from the article]